[ad_1]
CEO Jim Rechtin said Humana is “not realizing the full promise of the company” and that market conditions remained challenging due to an interest-rate environment “that has not kept pace with accelerated medical cost trends.”
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...